Ng KW - Search Results

1

Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.

Martin TJ, Sims NA, Ng KW. Martin TJ, et al. Among authors: ng kw. Osteoporos Int. 2008 Aug;19(8):1125-38. doi: 10.1007/s00198-008-0575-5. Epub 2008 Mar 13. Osteoporos Int. 2008. PMID: 18338097 Review.

2

Potential role of odanacatib in the treatment of osteoporosis.

Ng KW. Ng KW. Clin Interv Aging. 2012;7:235-47. doi: 10.2147/CIA.S26729. Epub 2012 Jul 12. Clin Interv Aging. 2012. PMID: 22866001 Free PMC article. Review.

3

Is Wnt signalling the final common pathway leading to bone formation?

Milat F, Ng KW. Milat F, et al. Among authors: ng kw. Mol Cell Endocrinol. 2009 Oct 30;310(1-2):52-62. doi: 10.1016/j.mce.2009.06.002. Epub 2009 Jun 12. Mol Cell Endocrinol. 2009. PMID: 19524639 Review.

4

Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo.

Kartsogiannis V, Sims NA, Quinn JM, Ly C, Cipetic M, Poulton IJ, Walker EC, Saleh H, McGregor NE, Wallace ME, Smyth MJ, Martin TJ, Zhou H, Ng KW, Gillespie MT. Kartsogiannis V, et al. Among authors: ng kw. J Biol Chem. 2008 Nov 7;283(45):30850-60. doi: 10.1074/jbc.M801761200. Epub 2008 Sep 8. J Biol Chem. 2008. PMID: 18782774 Free PMC article.

5

Cell lines and primary cell cultures in the study of bone cell biology.

Kartsogiannis V, Ng KW. Kartsogiannis V, et al. Among authors: ng kw. Mol Cell Endocrinol. 2004 Dec 30;228(1-2):79-102. doi: 10.1016/j.mce.2003.06.002. Mol Cell Endocrinol. 2004. PMID: 15541574 Review.

6

Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.

Hu YS, Zhou H, Myers D, Quinn JM, Atkins GJ, Ly C, Gange C, Kartsogiannis V, Elliott J, Kostakis P, Zannettino AC, Cromer B, McKinstry WJ, Findlay DM, Gillespie MT, Ng KW. Hu YS, et al. Among authors: ng kw. J Bone Miner Res. 2004 Jan;19(1):89-99. doi: 10.1359/JBMR.0301215. J Bone Miner Res. 2004. PMID: 14753741

7

New therapeutics for osteoporosis.

Ng KW, Martin TJ. Ng KW, et al. Curr Opin Pharmacol. 2014 Jun;16:58-63. doi: 10.1016/j.coph.2014.03.004. Epub 2014 Mar 31. Curr Opin Pharmacol. 2014. PMID: 24699340 Review.

8

Regulation of glucose metabolism and the skeleton.

Ng KW. Ng KW. Clin Endocrinol (Oxf). 2011 Aug;75(2):147-55. doi: 10.1111/j.1365-2265.2011.04133.x. Clin Endocrinol (Oxf). 2011. PMID: 21623861 Review.

9

Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.

Sims NA, Ng KW. Sims NA, et al. Among authors: ng kw. Curr Osteoporos Rep. 2014 Mar;12(1):98-106. doi: 10.1007/s11914-014-0196-1. Curr Osteoporos Rep. 2014. PMID: 24477416 Review.

10

Future developments in osteoporosis therapy.

Ng KW. Ng KW. Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):371-84. doi: 10.2174/187153009789839192. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19857200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results